← SynDRA
BERZOSERTIB
SynDRA canonical compound SYN0039103 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | ATR |
| Mechanism of action | ATR kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- ATR kinase inhibitor
- ATR inhibitor
- Serine-protein kinase ATR inhibitor
- ATM inhibitor
- MTOR inhibitor
- PIK3CG INHIBITOR
Cross-references
Synonyms
- VX-970
- BERZOSERTIB (VE-822)
- M-6620
- M6620
- VE-822
- VE-822 (BERZOSERTIB)
- VE822
- VX970
- VE 822
- VX 970
- L423PRV3V3
- M 6620
- berzosertibum
- RefChem:917027
- Berzosertib (VE-822)
- MFCD27976794
- Berzosertib [USAN]
- VE-822 (VX-970)
- A1EIE
- BDBM50226746
- US10208027, Compound II-2
- UNII-L423PRV3V3
- VX-970;Berzosertib
- BERZOSERTIB [INN]
- Berzosertib (USAN/INN)
- VE-822 (Berzosertib)
- VE-822 (Berzosertib)?
- BERZOSERTIB [WHO-DD]
- GTPL8003
- orb1701146
- SCHEMBL3061890
- SCHEMBL30514080
- EX-A529
- CHEBI:131166
- BDBM350085
- BDBM350086
- GLXC-90024
- HMS3653C05
- HMS3747I11
Look up BERZOSERTIB in the interactive SynDRA portal →